Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001011081 | SCV001171362 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-02-18 | criteria provided, single submitter | clinical testing | The p.L451I variant (also known as c.1351T>A), located in coding exon 4 of the PALB2 gene, results from a T to A substitution at nucleotide position 1351. The leucine at codon 451 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003473565 | SCV004202000 | uncertain significance | Familial cancer of breast | 2023-10-26 | criteria provided, single submitter | clinical testing |